去脂体重指数作为肌少症低肌肉量筛查中四肢骨骼肌质量指数的替代指标
本研究为横断面研究,纳入1313名40-87岁成人,采用多频生物电阻抗分析(BIA)和双能X线吸收法(DXA)测量体成分,分析BIA测得的去脂体重指数(FFMI)与四肢骨骼肌质量指数(ASMI)的关系,并计算筛查低肌肉量的最佳FFMI切点。结果显示FFMI与BIA及DXA测得的ASMI均呈强正相关,不受年龄和肥胖影响,可作为社区肌少症低肌肉量筛查的简易替代指标。
要点
- BIA测得的FFMI与BIA及DXA测得的ASMI均呈强正相关(r分别为0.96和0.95)。
- 筛查DXA定义的低肌肉量时,男性FFMI最佳切点为17.5 kg/m2(敏感度89%,特异度88%),女性为14.6 kg/m2(敏感度80%,特异度86%)。
- 建议预测低肌肉量的FFMI切点为男性<18 kg/m2、女性<15 kg/m2。
核心结论
- FFMI与BIA和DXA测得的ASMI均呈强正相关,且不受年龄和肥胖影响。
- FFMI可作为社区肌少症低肌肉量筛查中ASMI的简易替代指标。
研究设计与样本
- 横断面研究,纳入1313名40-87岁成人(女性占33.6%,平均年龄55±10岁),来自WASEDA'S Health Study。
- 体成分采用多频BIA和DXA测量,低肌肉量依据亚洲肌少症工作组2019标准定义。
主要发现
- BIA测得的FFMI与BIA测得的ASMI呈强正相关(r=0.96),与DXA测得的ASMI也呈强正相关(r=0.95)。
- 按年龄和肥胖分亚组分析,FFMI仍与ASMI相关。
- 以BIA测得的FFMI筛查DXA定义的低肌肉量,男性ROC曲线下面积为0.95(95%CI 0.93-0.97),女性为0.91(95%CI 0.87-0.94)。
关键数值与推荐
- 筛查DXA定义的低肌肉量,BIA测得的FFMI最佳切点:男性17.5 kg/m2(敏感度89%,特异度88%),女性14.6 kg/m2(敏感度80%,特异度86%)。
- 建议预测低肌肉量的FFMI切点为男性<18 kg/m2、女性<15 kg/m2。
临床怎么用
- 在社区场景中,可采用BIA测得的FFMI作为ASMI的简易替代指标进行肌少症低肌肉量筛查。
- 可参考FFMI切点(男性<18 kg/m2、女性<15 kg/m2)提示低肌肉量风险,但需结合DXA等确诊检查。
局限性
- 本研究为横断面研究,无法推断因果关系。
- 研究人群来自WASEDA'S Health Study,年龄40-87岁,外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to examine the relationship between the fat-free mass index (FFMI; FFM/height2) and appendicular skeletal muscle mass index (ASMI; ASM/height2), measured using both bioelectrical impedance analysis (BIA) and dual-energy X-ray absorptiometry (DXA), and investigate the effects of age and obesity. We also evaluated the suitability of BIA-measured FFMI as a simple surrogate marker of the ASMI and calculated the optimal FFMI cutoff value for low muscle mass screening to diagnose sarcopenia. DESIGN: Cross-sectional study. SETTING AND PARTICIPANTS: This study included 1313 adults (women, 33.6%) aged 40-87 years (mean age, 55 ± 10 years) from the WASEDA'S Health Study. METHODS: Body composition was measured using multifrequency BIA and DXA. Low muscle mass was defined according to the criteria of the Asian Working Group for Sarcopenia 2019. RESULTS: BIA-measured FFMI showed strong positive correlations with both BIA- (r = 0.96) and DXA-measured (r = 0.95) ASMIs. Similarly, in the subgroup analysis according to age and obesity, the FFMI was correlated with the ASMI. The areas under the receiver operating characteristic curve for screening low muscle mass defined by DXA-measured ASMI using BIA-measured FFMI values were 0.95 (95% CI 0.93-0.97) for men and 0.91 (95% CI 0.87-0.94) for women. The optimal BIA-measured FFMI cutoff values for screening low muscle mass defined by DXA-measured ASMI were 17.5 kg/m2 (sensitivity 89%, specificity 88%) for men and 14.6 kg/m2 (sensitivity 80%, specificity 86%) for women. CONCLUSIONS AND IMPLICATIONS: The FFMI showed a strong positive correlation with BIA- and DXA-measured ASMIs, regardless of age and obesity. The FFMI could be a useful simple surrogate marker of the ASMI for low muscle mass screening in sarcopenia in community settings. The suggested FFMI cutoff values for predicting low muscle mass are <18 kg/m2 in men and <15 kg/m2 in women.
引用
- Kawakami R, Tanisawa K, Ito T, et al. Fat-Free Mass Index as a Surrogate Marker of Appendicular Skeletal Muscle Mass Index for Low Muscle Mass Screening in Sarcopenia. J Am Med Dir Assoc. 2022. PMID: 36179769. doi:10.1016/j.jamda.2022.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。